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ABSTRACT
This article, co-authored by a psoriatic arthritis
(PsA) patient and a physician who regularly
encounters and treats PsA patients, discusses the
patient’s experience of living with the disease,
from diagnosis through living with the disease
day-to-day and other people’s reactions to their
treatment experiences and responses. The
physician adds to this by providing his
experiences in treating PsA with biologics, and
the importance of patients working together with
their rheumatologists to maximize the efficacy of
treatments and improve patients’ quality of life.
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PATIENT’S EXPERIENCE
Growing up in a small town in Texas, I heard
the phrases ‘‘Push through the pain’’ and ‘‘Walk
it off’’ many times. At that time, the source of
the pain was some rigorous task or a sports
injury. I am now 42 years old and I have to
mentally repeat those phrases to myself daily.
However, the source of the pain has now
changed to psoriatic arthritis (PsA).
I was diagnosed with severe plaque psoriasis
at the age of 7 after recovering from
chickenpox. I have been on just about every
medication available since 1980. I have used
coal tar creams, light therapy, sulfur-based oral
pills, steroid creams, immunosuppressive
biologic injections, and, most recently,
anti-inflammatory oral medication.
My first bad flare-up of PsA happened 5 years
ago and was likely delayed because of the
biologic medication used to treat my skin. My
skin was almost clear and my dermatologist and
I decided to transition back to a topical
treatment. It was about a month after that
transition that I noticed my hips were starting
to get stiff and sore. My hands, knees, and
ankles soon developed the same pain and
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stiffness. My co-workers started making
comments that I had a noticeable limp and
wanted to know if everything was okay. A
rheumatologist confirmed that I have PsA and
suggested that I return to using biologics.
Life with PsA has been a struggle, to say the
least. Stereotypically, arthritis is supposed to be
something that people over 60 have to deal
with, not people in their thirties. I now
understand and appreciate the TV
commercials for over-the-counter medications
with arthritis-friendly caps. I can usually do as
much walking as I want, but strenuous exercise
is not possible. I recently visited the Texas State
Fair and noticed that after taking around 15,000
steps, my joints started to burn, swell, and get
stiff.
I have always been a strong man. Words like
‘‘can’t’’ and ‘‘unable’’ are not in the dictionary to
describe myself. My parents have always told
me that I can do anything if I have the desire
and drive to do so. Now, a pickle jar is one of my
worst enemies and I often have to ask for help. I
know I cannot get out in the yard with my
nephews and play football. I volunteer for
several different organizations in my town and
I have to give serious consideration before I
accept any request for physical assistance. That
is not how I would prefer to live. I can accept
and deal with the emotional baggage that
comes with my own physical limitations.
However, the part that is the hardest is having
people call me lazy because I cannot keep up
with them or have to turn down their request
for help. They do not understand the pain and
what my limitations are. After explaining why I
cannot help or keep up, some understand and
are nice about it but never ask for my help
again. Others are just rude and continue to call
me lazy because ‘‘you just don’t want to help’’ or
‘‘you’re faking it.’’ As someone who has been so
self-sufficient and independent my entire life,
that hurts me deeper than anything. I would
love to help everyone with everything, but my
‘‘new normal’’ with PsA keeps me from doing so.
Many readers with arthritis will most likely
be able to connect with all I have written. I
also acknowledge that many of you have had
exponentially more difficult struggles. I would
like to encourage those of you in this category
to keep fighting. Please educate those around
you about your own struggles. When someone
offers to help, please let them do so. I would
also encourage you to become your doctor’s
biggest cheerleader. If you notice that your
treatment is helping, even though you may
not be back to 100 %, send them a note or call
and thank them. Your doctor is also a person
and cares enough about you that they went to
school to have the chance to treat your
condition. I can say with certainty that my
dermatologist and I are a team when it comes
to my treatment. I am always looking for new
treatments and she is open to discuss
anything I bring to her. If after her own
research she does not think the treatment
would be best for me, she explains why
instead of just saying no.
For the doctors reading this, I say thank you.
You may see patients every day who act like
they do not care, but what you do matters. I
pray that each one of you never arrives at a
point where you are so busy and burned out
that you become callous and stop caring. Many
of us who struggle with PsA only pour out our
aches and pains because you are the source of
our relief. We may not tell or trust anyone else
to understand. Finally, put the iPad or
chart aside, smile, and listen to your patients.
We greatly appreciate it. You will find us all to
be much happier when we feel we have been
heard.
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PHYSICIAN’S PERSPECTIVE
The patient’s experience brings up a great
number of salient points worth further
discussion. PsA occurs in an estimated
15–35 % of patients with psoriasis and
typically, as in this patient, occurs years after
the onset of the psoriatic lesions. Whether the
development of this patient’s arthritis
component was delayed because of his use of
biological therapy is unclear; it may have been,
as the patient suggests, depending on the type
of biologic therapy used (not all biologic
therapy is very effective for PsA) or he could
have experienced the natural history of disease.
Involvement of the hips as the first
manifestation of PsA is somewhat unusual: the
patient may well have had entheseal
involvement, rather than true joint
involvement, as the first manifestation of
systemic involvement of PsA (rather than
synovitis) which is not uncommon.
As the patient points out, the stereotype of
‘‘arthritis’’ is that it occurs almost exclusively in
older patients who are considered senior
citizens. While this may be somewhat true of
osteoarthritis, although many patients with this
disorder are younger than 60, it is not true of
patients with inflammatory arthritis or systemic
rheumatic diseases such as PsA, ankylosing
spondylitis, systemic lupus erythematosus,
rheumatoid arthritis, scleroderma, gout, etc.,
which typically have their first manifestations
in younger individuals initially occurring at any
time from their teens into their fifties.
It is imperative that a patient with PsA this
active sees a rheumatologist for management of
their PsA. It is not uncommon for a
dermatologist and rheumatologist to co-treat a
patient, but, the rheumatologist is usually
much more aggressive with respect to
treatment of the systemic manifestations of
disease, including the joints.
The patient describes very well what I hear
every day as a rheumatologist; the major
difficulties that patients have with their
systemic inflammatory arthritis is not
necessarily the pain and stiffness in joints but
the frustrations with their inability to do
normal activities of daily living and the
inability of others to understand why they are
limited; this can be the most depressing part of
their arthritis.
This patient makes a very valuable point to
individuals with inflammatory arthritis which
all should take to heart: patients with
disabilities secondary to an inflammatory
arthritis, who refuse to let the discomfort and
disability control them, but who do as much as
they can in spite of their discomfort and
limitations, are much more productive,
accomplish more, are more self-sufficient and
are happier than those who let their limitations
and pain control them.
Almost all rheumatologists are very vested in
treating patients with inflammatory arthritis
and have great satisfaction when their patients
do well. Most rheumatologists would like to
dispense with having to work on the computer
or iPad and be able to look at the patient during
their visit; this has been a major change in the
practice of medicine over the past 5 years in the
United States. It has led to a marked loss of
efficiency by the physician and a loss in
face-to-face contact of the patient and
physician with some deterioration of
patient–physician relationship. These changes
have been forced on physicians by our elected
officials and the insurance industry and are now
Federal law. As much as many physicians would
like to go back to the days when there was a true
patient–physician relationship, with no
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interference of computers, this is unlikely to
happen as we have gone down the road too far.
In spite of this, almost all physicians still listen
as well as they did previously; it just is not as
obvious to the patient.
PsA can be treated and patients with PsA can
be productive members of society. It is a
partnership.
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